Report overview
Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.
This report aims to provide a comprehensive presentation of the global market for Sexual Dysfunction Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexual Dysfunction Drugs. This report contains market size and forecasts of Sexual Dysfunction Drugs in global, including the following market information:
Global Sexual Dysfunction Drugs Market Revenue, 2019-2024, 2024-2029, ($ millions)
Global Sexual Dysfunction Drugs Market Sales, 2019-2024, 2024-2029, (K Pcs)
Global top five Sexual Dysfunction Drugs companies in 2023 (%)
The global Sexual Dysfunction Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The sexual dysfunction oral drugs segment accounted for the majority market share during 2017 and will continue to grow during the forecast period. The increasing cases of sexual dysfunctions are driving the need for oral therapies such as 5HT1A receptor agonist. The demand for sexual dysfunction oral drugs such as ED drugs will further increase due to the rising awareness among healthcare professionals.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sexual Dysfunction Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sexual Dysfunction Drugs Market, by Type, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Sexual Dysfunction Drugs Market Segment Percentages, by Type, 2023 (%)
Oral Therapy
Intracavernosal Therapy
Hormonal Therapy
Transurethral Therapy
Global Sexual Dysfunction Drugs Market, by User, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Sexual Dysfunction Drugs Market Segment Percentages, by User, 2023 (%)
Male
Female
Global Sexual Dysfunction Drugs Market, By Region and Country, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Sexual Dysfunction Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sexual Dysfunction Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Sexual Dysfunction Drugs revenues share in global market, 2023 (%)
Key companies Sexual Dysfunction Drugs sales in global market, 2019-2024 (Estimated), (K Pcs)
Key companies Sexual Dysfunction Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GlaxoSmithKline
Merck
Eli Lilly
AbbVie
Bayer
Teva Pharmaceutical Industries
Takeda
Apricus Biosciences
Emotional Brain
Ivix LLX
Leadiant Biosciences
NexMed
S1 Biopharma
Vietstar Biomedical Research
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sexual Dysfunction Drugs, market overview.
Chapter 2: Global Sexual Dysfunction Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Sexual Dysfunction Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by user, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sexual Dysfunction Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Sexual Dysfunction Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
